Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -1.59%19 Days Payable is 15.27 as of Jun. 2026, which is 66% above its 10-year median of 9.20. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 613 Healthcare Providers & Services companies, Medeze Group PCL ranks worse than 89.72% on this metric.
The historical rank and industry rank for Medeze Group PCL's Days Payable or its related term are showing as below:
BKK:MEDEZE'
s Days Payable Range Over the Past 10 Years
Min: 7.6 Med: 9.2 Max: 12.53
Current: 12.53
During the past 3 years, Medeze Group PCL's highest Days Payable was 12.53. The lowest was 7.60. And the median was 9.20.
BKK:MEDEZE's Days Payable is ranked worse than 89.72% of 613
companies
in the Healthcare Providers & Services industry
Industry Median: 58.16
vs BKK:MEDEZE: 12.53
Medeze Group PCL's Days Payable
increased
from Jun. 2025 (11.02) to Jun. 2026 (15.27).
It may suggest that Medeze Group PCLdelayed paying its suppliers.
The historical data trend for Medeze Group PCL's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MEDEZE vs HCA, THC, EHC: Days Payable Comparison
For the Medical Care Facilities subindustry, Medeze Group PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medeze Group PCL's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a Days Payable of 15.27 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medeze Group PCL and its competitors. This is 66% above median its historical median of 9.20. Over the past decade, Medeze Group PCL's Days Payable has ranged from 7.60 to 12.53. According to the industry distribution chart, Medeze Group PCL ranks #550 out of 613 companies in the Healthcare Providers & Services industry, placing it in the top 89.7%.
Is Medeze Group PCL's Days Payable too high?
Medeze Group PCL's current Days Payable of 15.27 is 66% above median its 10-year median of 9.20. Over the past 10 years, this metric has ranged from a low of 7.60 to a high of 12.53. The Healthcare Providers & Services industry median Days Payable is 58.16. Medeze Group PCL's value of 15.27 is 73.7% below this industry median. Based on the distribution chart, Medeze Group PCL ranks #550 out of 613 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #550 out of 613 companies for Days Payable. This places Medeze Group PCL in the lower half of its industry. The industry median Days Payable is 58.16. Medeze Group PCL's value of 15.27 is 73.7% below this benchmark. Historically, Medeze Group PCL's own Days Payable has ranged from 7.60 to 12.53 over the past decade. While the company's 10-year median is 9.20 vs. the industry median of 58.16, Medeze Group PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current Days Payable of 15.27 is 73.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current Days Payable is 15.27, which is 66% above median its own 10-year median of 9.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current Days Payable of 15.27. The current Days Payable is 15.27, which is 66% above median its 10-year median of 9.20 and 73.7% below the Healthcare Providers & Services industry median of 58.16. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current Days Payable is 15.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
